Matches in Nanopublications for { ?s ?p "[RAF and MEK inhibitors show remarkable clinical efficacy in BRAF(V600E) melanoma; however, resistance to these agents remains a formidable challenge.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[RAF and MEK inhibitors show remarkable clinical efficacy in BRAF(V600E) melanoma; however, resistance to these agents remains a formidable challenge.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[RAF and MEK inhibitors show remarkable clinical efficacy in BRAF(V600E) melanoma; however, resistance to these agents remains a formidable challenge.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[RAF and MEK inhibitors show remarkable clinical efficacy in BRAF(V600E) melanoma; however, resistance to these agents remains a formidable challenge.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1124468.RAa9zIjA-4n27ZtFzz-NSbQylVmdBhnRbGoP-76l6HHyo130_assertion description "[RAF and MEK inhibitors show remarkable clinical efficacy in BRAF(V600E) melanoma; however, resistance to these agents remains a formidable challenge.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124468.RAa9zIjA-4n27ZtFzz-NSbQylVmdBhnRbGoP-76l6HHyo130_provenance.
- NP1124460.RAnE6aIXxJHtDUCwhbyYKyKxIqsigqisPZ0WwBJ7sdeTg130_assertion description "[RAF and MEK inhibitors show remarkable clinical efficacy in BRAF(V600E) melanoma; however, resistance to these agents remains a formidable challenge.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124460.RAnE6aIXxJHtDUCwhbyYKyKxIqsigqisPZ0WwBJ7sdeTg130_provenance.
- NP1124463.RAiR5drEYlidmUZGz61YWHgveu0BZ6prEVhzIs51h5enM130_assertion description "[RAF and MEK inhibitors show remarkable clinical efficacy in BRAF(V600E) melanoma; however, resistance to these agents remains a formidable challenge.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124463.RAiR5drEYlidmUZGz61YWHgveu0BZ6prEVhzIs51h5enM130_provenance.